Rhythm Pharmaceuticals
RYTM
RYTM
203 hedge funds and large institutions have $3.63B invested in Rhythm Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 65 increasing their positions, 53 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
203
Holders Change
+28
Holders Change %
+16%
% of All Funds
2.7%
Holding in Top 10
11
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+10%
% of All Funds
0.15%
New
53
Increased
65
Reduced
53
Closed
24
Calls
$26.8M
Puts
$1.76M
Net Calls
+$25M
Net Calls Change
-$16.2M
Top Buyers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
$68.3M |
| 2 |
Marshall Wace
London,
United Kingdom
|
$38.8M |
| 3 |
JPMorgan Chase & Co
New York
|
$14.8M |
| 4 |
UBS Group
Zurich,
Switzerland
|
$14.2M |
| 5 |
SC
Stempoint Capital
New York
|
$11.6M |
